These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6423543)

  • 1. Efficacy of Mycobacterium bovis BCG vaccination in mice undergoing prior pulmonary infection with atypical mycobacteria.
    Orme IM; Collins FM
    Infect Immun; 1984 Apr; 44(1):28-32. PubMed ID: 6423543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic effect in mice of BCG vaccination against nontuberculous mycobacterial infections.
    Orme IM; Collins FM
    Tubercle; 1985 Jun; 66(2):117-20. PubMed ID: 4024269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis.
    Brandt L; Feino Cunha J; Weinreich Olsen A; Chilima B; Hirsch P; Appelberg R; Andersen P
    Infect Immun; 2002 Feb; 70(2):672-8. PubMed ID: 11796598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection with Mycobacterium kansasii and efficacy of vaccination against tuberculosis.
    Orme IM; Collins FM
    Immunology; 1983 Dec; 50(4):581-6. PubMed ID: 6228515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte recruitment and protective efficacy against pulmonary mycobacterial infection are independent of the route of prior Mycobacterium bovis BCG immunization.
    Palendira U; Bean AG; Feng CG; Britton WJ
    Infect Immun; 2002 Mar; 70(3):1410-6. PubMed ID: 11854227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of evidence for a reduction in the efficacy of subcutaneous BCG vaccination in mice infected with nontuberculous mycobacteria.
    Orme IM; Roberts AR; Collins FM
    Tubercle; 1986 Mar; 67(1):41-6. PubMed ID: 3715982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the MAIS-Group.
    Lozes E; Denis O; Drowart A; Jurion F; Palfliet K; Vanonckelen A; De Bruyn J; De Cock M; Van Vooren JP; Huygen K
    Scand J Immunol; 1997 Jul; 46(1):16-26. PubMed ID: 9246204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens.
    Demangel C; Garnier T; Rosenkrands I; Cole ST
    Infect Immun; 2005 Apr; 73(4):2190-6. PubMed ID: 15784562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Tolerance to Environmental Mycobacteria Interferes with Intradermal, but Not Pulmonary, Immunization against Tuberculosis.
    Price DN; Kusewitt DF; Lino CA; McBride AA; Muttil P
    PLoS Pathog; 2016 May; 12(5):e1005614. PubMed ID: 27153120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of various mycobacteria and the corresponding levels of cross-protection developed between species.
    Collins FM
    Infect Immun; 1971 Dec; 4(6):688-96. PubMed ID: 5005311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW; Wards BJ; Buddle BM; Collins DM
    Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination.
    Young SL; Slobbe L; Wilson R; Buddle BM; de Lisle GW; Buchan GS
    Infect Immun; 2007 Jun; 75(6):2833-40. PubMed ID: 17371857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Mycobacterium bovis BCG vaccination on interleukin-1 beta and RANTES mRNA expression in guinea pig cells exposed to attenuated and virulent mycobacteria.
    Jeevan A; Yoshimura T; Foster G; McMurray DN
    Infect Immun; 2002 Mar; 70(3):1245-53. PubMed ID: 11854207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
    Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S
    Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequence of prior exposure to environmental mycobacteria on BCG vaccination and diagnosis of tuberculosis infection.
    Thom M; Howard C; Villarreal-Ramos B; Mead E; Vordermeier M; Hope J
    Tuberculosis (Edinb); 2008 Jul; 88(4):324-34. PubMed ID: 18329343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The genetic regulation of host response to inoculation with Mycobacterium bovis (BCG) and Mycobacterium tuberculosis H37RV].
    Nikonenko BV; Mezhlumova MB; Moroz AM
    Biull Eksp Biol Med; 1990 Nov; 110(11):526-8. PubMed ID: 2128037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
    Yamamoto T; Lasco TM; Uchida K; Goto Y; Jeevan A; McFarland C; Ly L; Yamamoto S; McMurray DN
    Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.